Practical guide to fast-tracking the supply of disinfectants during COVID-19 published today

The Cross-Industry Alliance on COVID-19 is publishing today a practical guide aiming at supporting companies that manufacture and supply disinfectants to combat the COVID-19 pandemic.

At the initiative of A.I.S.E., EBPF (the European Biocidal Products Forum, a sector group of CEFIC) and FECC (the European Association of Chemical Distributors), a cross-industry alliance on COVID-19 was created. The main objective of the alliance is to provide industry with faster access to the relevant information, helping them to ensure that the authorities, medical facilities and the public all have enough supply of valuable disinfectants in this time of need.

Under the umbrella of the alliance, a practical guide has been developed with the voluntary contribution of CEHTRA (Consultancy for Environmental & Human Toxicology and Risk Assessment), and the law firms Fieldfisher (Belgium) LLP and Steptoe & Johnson LLP. 
This guide aims to assist companies in complying with their obligations under the Biocidal Products Regulation (BPR) and equivalent national laws on biocides during the COVID-19 pandemic.

The content of this ‘Practical Guide’ sets out the main procedures for fast-tracking the availability of disinfectants in order to help fight the pandemic
  • Appendix 1 provides an overview of national measures (either under the Article 55 of BPR and/or national laws) that have been adopted in various European countries [Please make sure to regularly check this link as this document is being updated on a regular basis by the authors.]
  • Appendix 2 lists all the active substances approved or under review for PT1 and PT2 at EU level. Further checks by companies with regards to the efficacy against encapsulated viruses, such as corona viruses should however be conducted.

Important note
This Practical Guide (and related appendices) is designed to be a living document and will be updated on a regular basis. Use of the information remains under the sole responsibility of the user. No liability is accepted with regard to the use that may be made of the information contained in this document.

Newsroom